Evidence map›Paper›PMID 37290827›Full record

ReviewJournal of the American Board of Family Medicine : JABFM2023

Integrating a Systematic, Comprehensive E-Cigarette and Vaping Assessment Tool into the Electronic Health Record.

Niharika Khanna, Elena Klyushnenkova, Adam Gaynor, Michael Dark, Julia Melamed, Melanie Bennett, Janaki Deepak

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the American Board of Family Medicine : JABFM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Niharika KhannaFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB) nkhanna@som.umaryland.edu.
Elena KlyushnenkovaFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).
Adam GaynorFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).
Michael DarkFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).
Julia MelamedFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).
Melanie BennettFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).
Janaki DeepakFrom the Department of Family and Community Medicine, University of Maryland, Baltimore, (NK, EK, AG, MD); Department of Internal Medicine, Department of Pulmonology and Critical Care, University of Maryland, Baltimore (JM, JD); Department of Psychiatry, University of Maryland, Baltimore (MB).

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
NCI NIH HHS P30 CA134274
6 · The paper itself

Abstract

backgroundRecently, the use of electronic cigarettes increased sharply, leading to increased e-cigarette, or Vaping Product Use-Associated Lung Injury (EVALI), and other acute pulmonary conditions. There is an urgent need for clinical information about e-cigarette users to identify factors that contribute to EVALI. We developed an e-cigarette/vaping assessment tool (EVAT) that was integrated into the Electronic Health Record (EHR) of a large state-wide medical system and initiated a system-wide dissemination and education to support its use.

methodsEVAT documented current vaping status, history, and e-cigarette content (nicotine, cannabinoids, and/or flavoring). Educational materials and presentations were developed via a comprehensive literature review. EVAT utilization in the EHR was assessed quarterly. Patients' demographic data and clinical site name were also collected.

resultsThe EVAT was built, validated, and integrated with the EHR in July 2020. Live and virtual seminars were conducted for prescribing providers and clinical staff. Asynchronous training was offered using podcasts, e-mails, and Epic tip sheets. Participants were informed about vaping harm and EVALI and instructed on the use of EVAT. As of December 31, 2022, EVAT was used 988,181 times, with 376,559 unique patients evaluated. Overall, 1,063 hospital units and affiliated ambulatory clinics used EVAT, including 64 Primary Care, 95 Pediatrics, and 874 Specialty sites.

conclusionsEVAT was successfully implemented. Continued outreach efforts are needed to further increase its usage. Education materials should be enhanced to help providers to reach youth and vulnerable populations and connect patients to the tobacco treatment resources.

Indexed as

Electronic Nicotine Delivery SystemsLung InjuryVapingAdolescentChildElectronic Health RecordsHumansNicotineNicotineAdolescentCannabinoidse-CigaretteElectronic Health RecordsLung InjuryMarylandNicotineVapingVulnerable Populations

Identifiers

PMID37290827
PMCPMC11221411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.